Hjem › Autoimmune sykdommer › Oregon
Kliniske studier for Autoimmune sykdommer i Oregon
9 studier for Autoimmune sykdommer søker deltakere på steder i Oregon.
Byer i Oregon
Offisiell studietekst (engelsk)
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Oregon Health & Science University, Portland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06722235RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Oregon Health & Science University - Accepting Adult Patients, Portland
RekruttererFase 2/3
Alder 6 til 75 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06154252A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Oregon Health & Science University, Portland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06948318RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Oregon Health & Science University, Portland
RekruttererFase 1/2
Alder 18 til 70 · Alle kjønn · Oppdatert 13. aug. 2026 · NCT06359041Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1031, Eugene
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 30. jul. 2026 · NCT07039916KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Oregon Health & Science University, Portland
RekruttererFase 2/3
Alder 18 til 75 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT06193889A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Oregon Health & Science University/Doernbecher Children's Hospital, Portland
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
- Oregon Health Sciences University, Portland
RekruttererFase 1
Alder 18 til 70 · Alle kjønn · Oppdatert 30. jun. 2026 · NCT06201416A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Oregon Health & Science University (OHSU), Portland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 25. feb. 2026 · NCT06626919Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.